Khaitan Eversheds and Norton Rose lead on United Drugs acquisition of Bilcare businesses for 61m

Bilcare Limited has signed an agreement with United Drug Plc. for the sale of its global clinical supplies (GCS) businesses in the U.S and U.K. The deal is valued at $61 million (Rs. 340 crore)..Khaitan & Co acted as Indian legal counsel to United Drug with a team led by Partner Rabindra Jhunjhunwala while Eversheds acted as International legal counsel with a team led by Partner Stephen Kitts..Norton Rose acted as the legal advisor to Bilcare..According to VCCircle, Bilcare has retained its GCS business in Asia and will work together with United Drug to use their complementary resources to meet the needs of their global customers across the US, Europe and Asia..This sale will enable Bilcare GCS Asia to focus its resources and better meet customer expectations of world-class services. It will also leverage United Drug’s capabilities and resources in the US and Europe..Founded in 1993 by Mohan Bhandari, Pune-based Bilcare Ltd provides solutions to the global pharmaceutical and healthcare industry to improve patient healthcare outcomes. It has manufacturing and R&D plants located across the US, Europe, India and Singapore..United Drug is a provider of outsourced solutions to healthcare companies operating across three divisions including healthcare supply chain, sales, marketing & medical, and packaging & specialty.